XML 28 R16.htm IDEA: XBRL DOCUMENT v3.5.0.2
Stock-Based Compensation (Tables)
3 Months Ended
Oct. 29, 2016
Stock-Based Compensation [Abstract]  
Stock-based compensation expense by type
The compensation costs that have been charged against income for the thirteen and thirty-nine weeks ended October 29, 2016 and October 31, 2015 were as follows (in thousands):

  
Thirteen Weeks Ended
  
Thirty-Nine Weeks Ended
 
  
October 29, 2016
  
October 31, 2015
  
October 29, 2016
  
October 31, 2015
 
Stock-based compensation expense by type:
            
Stock options
 
$
-
  
$
16
  
$
384
  
$
375
 
Restricted stock unit awards, including performance-based
  
629
   
815
   
3,237
   
3,980
 
Employee stock purchases
  
22
   
23
   
80
   
81
 
Director deferred compensation
  
24
   
18
   
70
   
53
 
Total stock-based compensation expense
  
675
   
872
   
3,771
   
4,489
 
Income tax benefit recognized
  
240
   
316
   
1,363
   
1,645
 
Stock-based compensation expense, net of income tax
 
$
435
  
$
556
  
$
2,408
  
$
2,844
 
Equity awards granted during the period
In the thirteen and thirty-nine weeks ended October 29, 2016 and October 31, 2015, we granted the following equity awards:

  
Thirteen Weeks Ended
  
Thirty-Nine Weeks Ended
 
  
October 29, 2016
  
October 31, 2015
  
October 29, 2016
  
October 31, 2015
 
Stock options
  
-
   
1,515
   
36,359
   
21,743
 
Restricted stock unit awards
  
-
   
-
   
100,775
   
69,529
 
Performance-based restricted stock unit awards
  
-
   
-
   
45,300
   
29,300
 
Deferred stock units
  
588
   
500
   
14,744
   
12,128
 
Employee Stock Purchases during the period
Our employee purchases of common stock, the average price per share and the weighted-average grant date fair value of shares purchased through our employee stock purchase plan were as follows:

  
Thirteen Weeks Ended
  
Thirty-Nine Weeks Ended
 
  
October 29, 2016
  
October 31, 2015
  
October 29, 2016
  
October 31, 2015
 
Shares purchased
  
3,236
   
3,114
   
11,874
   
8,605
 
Average price per share
 
$
29.29
  
$
29.76
  
$
27.66
  
$
36.66
 
Weighted average fair value at grant date
 
$
7.25
  
$
10.01
  
$
6.94
  
$
10.35